Your browser doesn't support javascript.
Shenhuang granule in the treatment of severe coronavirus disease 2019 (COVID-19): study protocol for an open-label randomized controlled clinical trial.
Fang, Bangjiang; Zhang, Wen; Wu, Xinxin; Huang, Tingrong; Li, Huacheng; Zheng, You; Che, Jinhua; Sun, Shuting; Jiang, Chao; Zhou, Shuang; Feng, Jun.
  • Fang B; Department of Emergency, LongHua Hospital, Shanghai University of Traditional Chinese Medicine, NO.725 Wanping South Road, Xuhui District, Shanghai, 200032, China.
  • Zhang W; Clinical Medical College of TCM, Hubei University of Chinese Medicine, NO.1 Tanhualin, Wuchang District, Wuhan, 430065, Hubei, China.
  • Wu X; Department of Emergency, LongHua Hospital, Shanghai University of Traditional Chinese Medicine, NO.725 Wanping South Road, Xuhui District, Shanghai, 200032, China.
  • Huang T; Department of Emergency, LongHua Hospital, Shanghai University of Traditional Chinese Medicine, NO.725 Wanping South Road, Xuhui District, Shanghai, 200032, China.
  • Li H; Huangshi Hospital of TCM (Infectious Disease Hospital), NO.6 Plaza Road, Huangshi Port District, Huangshi, 435000, Hubei, China.
  • Zheng Y; Huangshi Hospital of TCM (Infectious Disease Hospital), NO.6 Plaza Road, Huangshi Port District, Huangshi, 435000, Hubei, China.
  • Che J; Huangshi Hospital of TCM (Infectious Disease Hospital), NO.6 Plaza Road, Huangshi Port District, Huangshi, 435000, Hubei, China.
  • Sun S; Department of Emergency, LongHua Hospital, Shanghai University of Traditional Chinese Medicine, NO.725 Wanping South Road, Xuhui District, Shanghai, 200032, China.
  • Jiang C; Clinical Medical College of TCM, Hubei University of Chinese Medicine, NO.1 Tanhualin, Wuchang District, Wuhan, 430065, Hubei, China.
  • Zhou S; The Third Department of Neurology, The Second Affiliated Hospital of Xi'an Medical University, NO.167, Textile City East Street, Baqiao District, Xi'an, 710032, Shanxi, China.
  • Feng J; Shanghai University of Traditional Chinese Medicine, 1200 Cai Lun Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai, 201203, China. zhoushuang8008@163.com.
Trials ; 21(1): 568, 2020 Jun 24.
Article in English | MEDLINE | ID: covidwho-612407
ABSTRACT

BACKGROUND:

Currently, coronavirus disease 2019 (COVID-19) is continuously and rapidly circulating, causing heavy damage on public health. No effective antiviral treatment has been proved thus far. Traditional Chinese medicine (TCM) has been widely applied in the treatment of a variety of infection diseases in China, hoping to produce clinical effects and reduce the use of antibiotics and glucocorticoid. The aim of this study is to evaluate the efficacy and safety of Shenhuang granule in treatment of severe COVID-19. METHODS/

DESIGN:

This multicenter, open-label randomized controlled trial is conducted in 160 participants with severe COVID-19. The participants will be randomly (11) divided into treatment group or control group. All participants are given standard therapy at the same time. The experiment will receive Shenhuang granule treatment twice a day for 14 days. The clinical indicators of patients will be assessed at baseline and at 3, 5, 7, and 14 days after treatment initiation. The primary outcome is 14-day clinical outcome. Adverse events will be monitored throughout the trial.

DISCUSSION:

This will be the first randomized controlled trial, which evaluate the effect of Shenhuang granule in patients with severe COVID-19 in China. The results of this trial may not only provide evidence-based recommendations to clinicians to treat severe COVID-19, but also enrich the theory and practice of TCM in treating infectious diseases. TRIAL REGISTRATION Chinese Clinical Trial Registry, ChiCTR2000029777. Registered on 13 February 2020.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Drugs, Chinese Herbal / Randomized Controlled Trials as Topic / Coronavirus Infections / Betacoronavirus / Medicine, Chinese Traditional Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Topics: Traditional medicine Limits: Adolescent / Adult / Aged / Humans / Middle aged / Young adult Language: English Journal: Trials Journal subject: Medicine / Therapeutics Year: 2020 Document Type: Article Affiliation country: S13063-020-04498-6

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Drugs, Chinese Herbal / Randomized Controlled Trials as Topic / Coronavirus Infections / Betacoronavirus / Medicine, Chinese Traditional Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Topics: Traditional medicine Limits: Adolescent / Adult / Aged / Humans / Middle aged / Young adult Language: English Journal: Trials Journal subject: Medicine / Therapeutics Year: 2020 Document Type: Article Affiliation country: S13063-020-04498-6